Skip to content
Toggle main navigation
PURPOSE logo
PURPOSE logo
  • Home
  • Events
  • Opportunities
  • News & Publications
  • T90/R90 HEAL Pain Cohort Program
  • Mobile App
  • About
  • Exhibit
  • Affiliate Networks
    • Music4Pain (U24)
    • ENSEMBLE Network (U24)
    • Pain Research Forum (PRF)
    • ForceNET (U24)
    • NeuronS_MATTR (U24)
    • SPINEWORK Network (U24)
    Log in
    Request to Join

    News & Publications

    Do you have news or publications to share with the PURPOSE Network? Submit your news below.

    Submit Your News or Publication
    All
    Acquired Cognitive Impairment
    Acupuncture
    Addiction
    Ageing
    Alcohol Use / Alcohol Use Disorder (AUD)
    Analgesics
    Analgesics, Topical
    Anatomy
    Anesthesia, General
    Anesthesia, Intravenous regional
    Anesthesia, Local
    Anesthesia, Spinal
    Animal Models
    Anxiety
    Arthritis, Rheumatoid
    See all

    Highlighted News

    Results (80)

    Current Status of Pain-Related Patient-Reported Outcomes and Perioperative Pain Management among 40,785 Patients: A Prospective Multicenter Study

    Current Status of Pain-Related Patient-Reported Outcomes and Perioperative Pain Management among 40,785 Patients: A Prospective Multicenter Study

    MedComm (2020). 2026 Nov 16;7(12):e71132. doi: 10.1002/mco2.71132. eCollection 2026 Dec.ABSTRACTThis study analyzed self-reported pain-related outcomes of 40,785 surgical patients from 125 centers collected by CAPOPS (China Acute Postoperative Pain Study) between September 2019 and August 2023, to characterize the current status of acute postoperative pain management protocols and pain prognoses i
    November 17, 2026
    Nonsteroidal anti-inflammatory drugs in chronic and relapsing musculoskeletal pain: pearls for clinical practice

    Nonsteroidal anti-inflammatory drugs in chronic and relapsing musculoskeletal pain: pearls for clinical practice

    Musculoskelet Surg. 2026 Nov 3. doi: 10.1007/s12306-026-00992-3. Online ahead of print.ABSTRACTNonsteroidal anti-inflammatory drugs (NSAIDs) are the principal pharmacological option for inflammatory musculoskeletal pain and are frequently treated as an interchangeable class from which any agent may be selected. This narrative review examines the pharmacological basis of that assumption and organis
    November 3, 2026
    Effects of perioperative esketamine infusion on chronic pain after video-assisted thoracoscopic lung resection: a multicentre, randomised, double-blind clinical trial

    Effects of perioperative esketamine infusion on chronic pain after video-assisted thoracoscopic lung resection: a multicentre, randomised, double-blind clinical trial

    Br J Anaesth. 2026 Oct 28:S0007-0912(26)00693-8. doi: 10.1016/j.bja.2026.08.039. Online ahead of print.ABSTRACTBACKGROUND: Chronic postsurgical pain after thoracoscopic surgery remains common. We investigated whether perioperative low-dose esketamine infusion would reduce chronic pain after video-assisted thoracoscopic lung resection.METHODS: In this multicentre, randomised controlled trial, 914 a
    October 29, 2026
    Regional analgesic techniques for postoperative pain after kidney transplantation: a systematic review and Bayesian meta-analysis

    Regional analgesic techniques for postoperative pain after kidney transplantation: a systematic review and Bayesian meta-analysis

    Br J Anaesth. 2026 Oct 27:S0007-0912(26)00738-5. doi: 10.1016/j.bja.2026.09.018. Online ahead of print.ABSTRACTBACKGROUND: Pain after kidney transplantation is often severe, and graft function constrains the use of systemic analgesia. Previous syntheses of regional techniques pooled them as a class, combined donors with recipients, and did not use a minimal clinically important difference (MCID).M
    October 28, 2026
    Over-the-counter topical diclofenac in musculoskeletal pain: clinical value, access and responsible use

    Over-the-counter topical diclofenac in musculoskeletal pain: clinical value, access and responsible use

    Curr Med Res Opin. 2026 Oct 22:1-7. doi: 10.1080/03007995.2026.2746838. Online ahead of print.ABSTRACTTopical non-steroidal anti-inflammatory drugs (NSAIDs), including diclofenac, are established options for localized musculoskeletal pain, with guidelines supporting their use in knee osteoarthritis, broader osteoarthritis management and acute non-low-back musculoskeletal injuries. For selected ind
    October 23, 2026
    Circadian-Psychosocial Profiling of Cancer Pain: A Mixed-Methods Study on Heterogeneous Subgroups and Personalized Analgesic Efficacy

    Circadian-Psychosocial Profiling of Cancer Pain: A Mixed-Methods Study on Heterogeneous Subgroups and Personalized Analgesic Efficacy

    Psychooncology. 2026 Oct;35(10):e70621. doi: 10.1002/pon.70621.ABSTRACTOBJECTIVE: To identify distinct cancer pain subgroups using integrated circadian, physiological and psychosocial data and assess subgroup-specific analgesic responses.METHODS: This explanatory sequential mixed-methods study included 191 adult inpatients with cancer pain from a tertiary care hospital. Quantitative measures inclu
    October 23, 2026
    Gelsemine attenuates neuropathic pain in a rat model of sciatic nerve chronic constriction injury

    Gelsemine attenuates neuropathic pain in a rat model of sciatic nerve chronic constriction injury

    Mol Pain. 2026 Jan-Dec;22:17448069261499174. doi: 10.1177/17448069261499174. Epub 2026 Oct 20.ABSTRACTObjective The effect of Gelsemine on neuropathic pain was investigated using a sciatic nerve (SN) chronic constriction injury (CCI) rat model.Methods Network pharmacology analysis was performed to identify potential molecular targets of Gelsemine associated with neuropathic pain, followed by molec
    October 22, 2026
    Intravenous ibuprofen versus ketorolac for acute low back pain in the emergency department: a triple-blind randomized clinical trial

    Intravenous ibuprofen versus ketorolac for acute low back pain in the emergency department: a triple-blind randomized clinical trial

    Intern Emerg Med. 2026 Oct 20. doi: 10.1007/s11739-026-04570-0. Online ahead of print.ABSTRACTConsidering the frequency of recurrence in low back pain (LBP), there is no single medication group with promising efficacy in acute settings. Non-steroidal anti-inflammatory drugs (NSAIDs) provide better pain relief with rather low complications. Since ketorolac has been relatively effective, we compared
    October 21, 2026
    Oliceridine and morphine differentially modulate the gut microbiota-intestinal barrier axis in a rat postoperative pain model

    Oliceridine and morphine differentially modulate the gut microbiota-intestinal barrier axis in a rat postoperative pain model

    Front Pharmacol. 2026 Oct 5;17:1907666. doi: 10.3389/fphar.2026.1907666. eCollection 2026.ABSTRACTBACKGROUND: Oliceridine is a novel G protein-biased μ-opioid receptor agonist with potentially improved gastrointestinal tolerability compared with conventional opioids. However, its impact on postoperative intestinal homeostasis-specifically the gut microbiota and intestinal barrier-remains poorly un
    October 20, 2026
    The analgesic efficacy of opioids in different application modalities for the treatment of breakthrough cancer pain-a systematic review with network meta-analysis

    The analgesic efficacy of opioids in different application modalities for the treatment of breakthrough cancer pain-a systematic review with network meta-analysis

    Pain. 2026 Oct 13. doi: 10.1097/j.pain.0000000000004132. Online ahead of print.ABSTRACTBreakthrough cancer pain episodes often require oral immediate release opioids or parenteral opioid treatment. Different formulations and application modalities have been approved for this condition. This study aimed to identify the most effective of the available substances and applications to treat breakthroug
    October 16, 2026
    Efficacy and Safety of Lidocaine Compared to Other Agents for Intrauterine Device Insertion Pain: A Systematic Review and Meta-Analysis

    Efficacy and Safety of Lidocaine Compared to Other Agents for Intrauterine Device Insertion Pain: A Systematic Review and Meta-Analysis

    BJOG. 2026 Oct 14. doi: 10.1111/1471-0528.70345. Online ahead of print.ABSTRACTBACKGROUND: Pain during intrauterine device (IUD) insertion remains a common barrier to use, with limited guidance on preferred pharmacological agents.OBJECTIVE: Evaluate the efficacy and safety of lidocaine compared to other pharmacologic agents for reducing pain during IUD insertion.SEARCH STRATEGY: Electronic databas
    October 15, 2026
    Cannabinoids for Acute Pain Management: A Contemporary Scoping Review of Evidence, Mechanisms, and Clinical Implications

    Cannabinoids for Acute Pain Management: A Contemporary Scoping Review of Evidence, Mechanisms, and Clinical Implications

    Curr Pharm Des. 2026 Oct 5. doi: 10.2174/0113816128510427260927100857. Online ahead of print.ABSTRACTBACKGROUND: The global opioid crisis has intensified interest in non-opioid and opioid-sparing analgesic strategies, including cannabinoids. Despite the expanding legal landscape for cannabis and a rapidly growing cannabinoid market, the clinical evidence for cannabinoid use in acute pain managemen
    October 13, 2026
    Progress in pain mechanisms and management

    Progress in pain mechanisms and management

    Signal Transduct Target Ther. 2026 Oct 13;11(1):444. doi: 10.1038/s41392-026-02931-x.ABSTRACTPain is a multifaceted sensory and emotional experience that profoundly affects human health and quality of life. It functions as a double-edged sword: while acute pain serves as a protective warning signal, chronic pain compromises physiological and psychological well-being. Pain is now widely regarded as
    October 13, 2026
    Combination spinal cord stimulation at different frequencies produces sustained pain relief with immune activation

    Combination spinal cord stimulation at different frequencies produces sustained pain relief with immune activation

    bioRxiv [Preprint]. 2026 Aug 12:2026.08.06.742589. doi: 10.64898/2026.08.06.742589.ABSTRACTSpinal cord stimulation (SCS) is an established therapy for neuropathic pain, typically delivered at either low (60 Hz) or high (1 kHz) frequencies, with analgesic effects largely dependent on active stimulation. Here, we investigated whether combined-frequency SCS produces sustained analgesia beyond stimula
    October 8, 2026
    Regularly Scheduled Acetaminophen for Pain in Long-Term Care: Systematic Review and Meta-Analysis

    Regularly Scheduled Acetaminophen for Pain in Long-Term Care: Systematic Review and Meta-Analysis

    J Am Med Dir Assoc. 2026 Oct 7;27(11):106432. doi: 10.1016/j.jamda.2026.106432. Online ahead of print.ABSTRACTOBJECTIVE: Pain is common among long-term care (LTC) residents, and acetaminophen is often recommended as first-line therapy. We aimed to determine whether regularly scheduled acetaminophen, compared with any comparator, improves pain outcomes in LTC.DESIGN: Systematic review and meta-anal
    October 8, 2026
    Cannabinoids for pain management in rheumatoid arthritis: a scoping review of clinical evidence and mechanisms

    Cannabinoids for pain management in rheumatoid arthritis: a scoping review of clinical evidence and mechanisms

    Rheumatol Int. 2026 Oct 5;46(10):275. doi: 10.1007/s00296-026-06314-x.ABSTRACTPersistent pain remains a major unmet need in rheumatoid arthritis (RA), even in patients with adequately controlled inflammatory disease. Cannabinoids have been proposed as potential modulators of pain and inflammation, but their clinical role in RA remains uncertain. To map and critically appraise the available clinica
    October 5, 2026
    Effect of simvastatin versus calcium hydroxide intracanal medications on postoperative pain and cytokine modulation in symptomatic apical periodontitis: a randomized controlled trial

    Effect of simvastatin versus calcium hydroxide intracanal medications on postoperative pain and cytokine modulation in symptomatic apical periodontitis: a randomized controlled trial

    BMC Oral Health. 2026 Sep 15;26(1):1751. doi: 10.1186/s12903-026-09793-3.ABSTRACTBACKGROUND: Calcium hydroxide has long been used as an intracanal medicament in endodontics and remains widely applied due to its well-established antimicrobial and anti-inflammatory properties. Owing to its clinical effectiveness, it is recommended for use in a variety of endodontic treatment situations. Simvastatin,
    September 17, 2026
    Impact of CYP Enzyme Polymorphisms on Opioid Response in Anesthesia and Pain Medicine

    Impact of CYP Enzyme Polymorphisms on Opioid Response in Anesthesia and Pain Medicine

    Pain Res Manag. 2026;2026(1):e6605418. doi: 10.1155/prm/6605418.ABSTRACTOpioids serve as the cornerstone for anesthesia, postoperative analgesia, and chronic pain management. However, significant interindividual variations exist in their efficacy and safety, posing substantial challenges to clinical practice. Genetic polymorphisms of Cytochrome P450 (CYP) enzymes, particularly CYP2D6 and CYP3A4/5,
    September 7, 2026
    Real-World Effectiveness and Safety of Imrecoxib Across Diverse Pain Conditions: A Multicenter, Retrospective Cohort Study of 30,214 Patients

    Real-World Effectiveness and Safety of Imrecoxib Across Diverse Pain Conditions: A Multicenter, Retrospective Cohort Study of 30,214 Patients

    Drug Des Devel Ther. 2026 Aug 28;20:623254. doi: 10.2147/DDDT.S623254. eCollection 2026.ABSTRACTBACKGROUND: Imrecoxib, a selective COX-2 inhibitor approved for osteoarthritis pain, has shown therapeutic potential in various inflammatory conditions. However, real-world evidence of application patterns and effectiveness in routine practice remains limited.METHODS: A non-interventional, registry-base
    September 2, 2026
    Intrathecal semaglutide attenuates burn injury-induced pain in mice through a spinal GLP-1R-linked enkephalin/delta-opioid receptor pathway

    Intrathecal semaglutide attenuates burn injury-induced pain in mice through a spinal GLP-1R-linked enkephalin/delta-opioid receptor pathway

    Neuropharmacology. 2026 Aug 30:111163. doi: 10.1016/j.neuropharm.2026.111163. Online ahead of print.ABSTRACTBurn injury-induced pain (BIP) is a complex condition whose spinal mechanisms remain incompletely understood. Although spinal glucagon-like peptide-1 receptor (GLP-1R) signaling has been implicated in pain modulation, its contribution to BIP remains unclear. Using a mouse model of second-deg
    August 31, 2026
    Contact
    Neurovations Education
    [email protected]

    United States

    PURPOSE@PainResearchers.com
    707-260-0848
    Links
    • NIH HEAL Initiative
    • Research in Pain Management